Trial Profile

A Phase I Study to Determine the Relative Bioavailability of Various Formulations of GDC-0134 in Healthy Female Subjects of Non-Childbearing Potential

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 02 Sep 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs GDC 0134 (Primary)
Indications Amyotrophic lateral sclerosis
Focus Pharmacokinetics
Sponsors Genentech

Most Recent Events

02 Aug 2019 Status changed from active, no longer recruiting to completed.
06 May 2019 Status changed from recruiting to active, no longer recruiting.
09 Apr 2019 Planned End Date changed from 9 Apr 2019 to 24 May 2019.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com